Commercialization: Page 12
-
PharmaVoice Team/PharmaVoice
Marketing to Zoomers
Pharma needs to gear up for the 2 billion Gen Zers about to enter the marketplace. If you’re looking for a snapshot of what Gen Z, or zoomers, means as an audience for your product, consider this: 16-year-old Swedish climate activist Greta Thunberg is a zoomer. Mari Copeny, who wrote a letter to ...
By Robin Robinson • June 1, 2021 -
PharmaVoice Team/PharmaVoice
A Public Crisis — Health Inequity
Tackling the link between health inequities, social injustice, and social determinants of health. The World Health Organization describes health as a fundamental human right. Yet, in much of the world, including the United States, health and social inequity are pervasive problems that systematica...
By Kim Ribbink • June 1, 2021 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Illuminating leadership When PharmaVOICE first had the honor of recognizing the Healthcare Businesswomen’s Association’s (HBA) Rising Stars in conjunction with the esteemed Woman of the Year back in 2005, there were 38 honorees. Fast forward 17 years, and the HBA is recognizing 156 Rising Stars a...
By Taren Grom • May 1, 2021 -
PharmaVoice Team/PharmaVoice
Artificial Intelligence
Model Medicines Partners with Sanford Burnham Prebys on AI-driven Drug Discovery Model Medicines, an AI drug discovery software company, has entered into a multi-target collaboration agreement with Sanford Burnham Prebys Medical Discovery Institute to identify and develop drugs for novel antivira...
By PharmaVoice Team • May 1, 2021 -
PharmaVoice Team/PharmaVoice
Modernizing Media Strategies
The pandemic created an opportunity for the industry to invest in and reap the benefits of new media tactics. Over the years, the pharmaceutical and healthcare industry had been hesitant about fully jumping on the social media bandwagon, but the pandemic of 2020 forced companies to go to places l...
By Robin Robinson • May 1, 2021 -
PharmaVoice Team/PharmaVoice
SHOWCASE: Brand Building: Omnichannel and the Future of Brand Building
Brand building today creates both more challenges and more opportunities for pharmaceutical companies to promote products and reach customers. With so many more stakeholders to cater for — patients, physicians, payers, regulators, as well as partners and shareholders — companies must ensure the r...
By PharmaVoice Team • May 1, 2021 -
PharmaVoice Team/PharmaVoice
If You Want To Be A Great Brand Builder, Learn How To Be A Great Gift Giver
I have heard seasoned professionals describe the present state of building biopharma brands as increasingly complicated, confusing, and messy. It requires the knowledge of multiple topics and an army of specialists. Marketers entrusted with building brands must know a lot about a lot. I agree. Bu...
By Ryan Mason • May 1, 2021 -
PharmaVoice Team/PharmaVoice
Expect More From Your Omnichannel Strategy and Investments
From ordering your Starbucks latte on your iPhone to skipping the line at Splash Mountain with your Disney Magic Band, omnichannel strategies transform how consumers interact with their favorite brands. The most successful brands create an immersive experience that meets the needs of their consum...
By Krista Pinto • May 1, 2021 -
PharmaVoice Team/PharmaVoice
Race to Expiration: Accelerating a Mature Brand Toward the Patent Cliff
Captaining a pharma product launch can be career-defining. The course is uncharted, the excitement tangible, and visibility is high. Beyond product launches, managing a brand’s early lifecycle can be reinvigorating, with additional indications, long-term clinical programs, and new commercial offe...
By Michael DiSalvo • May 1, 2021 -
PharmaVoice Team/PharmaVoice
Shifting Pharma Marketing Dollars in a Post-Covid Environment
As we settle into an updated way of marketing, some things are becoming clear. The old ways of allocating marketing dollars need to be reassessed. As the reality of 2020 has given way to the promise of 2021, we’ve seen some new, creative ways to capture audiences as well as a revival of some prov...
By Nick Bellomo • May 1, 2021 -
PharmaVoice Team/PharmaVoice
The Foundations of Brand Building
Like the design and construction of a skyscraper, the fundamentals of successful brand building start with a rock-solid foundation — an infrastructure demanding strength, rigidity, and careful planning to ensure unwavering support from which to raise the brand. This groundwork is the most crucial...
By Samantha Glasgow • May 1, 2021 -
PharmaVoice Team/PharmaVoice
SHOWCASE: Connected Health: COVID and the Rapid Rise of Connected Health
COVID-19 has accelerated the adoption of self-care healthcare products, services, and tools, which will continue to transform the landscape of healthcare delivery and innovation beyond 2021. Globally, governments and health authorities have been putting in place policies to support and enable th...
By PharmaVoice Team • May 1, 2021 -
PharmaVoice Team/PharmaVoice
Connected Health — Establishing Valuable Relationships at Every Step of the Patient Journey
Opportunities for Connected Health Connected health provides a window into patients’ lives, helping to characterize what’s happening with them. There’s a technical and personal connection at play. We get an opportunity to reach out into the daily life of a patient — whether they’re participating ...
By Randy Swanson • May 1, 2021 -
PharmaVoice Team/PharmaVoice
Zooming In for Promotional Medical Education
With all medical education forced to go virtual, the industry has been working hard to ensure peer-to-peer engagements cut through the clutter. For the past year, all forms of learning have been forced to go virtual. For the pharmaceutical industry and associations managing non-accredited medical...
By Kim Ribbink • May 1, 2021 -
PharmaVoice Team/PharmaVoice
Speak Out: 3 Steps to Consider When Launching a Product in Today's Market
Fit-for-purpose planning, agile execution, and informed investment decisions Successful product launches are crucial to the future viability of pharmaceutical and biotechnology companies but are no longer a straightforward feat. Let’s consider product launches in the recent years. U.S. pharmaceut...
By Maya Desai • May 1, 2021 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Password protected? How secure is your healthcare and other online data? Well, across the globe it’s clear that healthcare information continues to be fertile ground for cybercriminals. According to HIPAA Journal, there was a 40.63% increase in reported data breaches of 500 or more healthcare rec...
By Taren Grom • April 1, 2021 -
PharmaVoice Team/PharmaVoice
Upfront
Astellas Oncology Fifth Annual C3 Prize Winners Astellas Oncology has named the winners of its 5th Annual C3 Prize(Changing Cancer Care), a global challenge that sparks cancer care innovations beyond medicine to advance ideas that make a big impact in the cancer community. The program awards up t...
By PharmaVoice Team • April 1, 2021 -
PharmaVoice Team/PharmaVoice
HealthTech
Robots Measure Vitals to Minimize Interactions with COVID Patients Trend Watch: COVID-19 Forces Healthtech Innovations from Robots to Partnerships Researchers at Simon Fraser University in Canada have developed three different robots that can sense and measure patients’ healthcare parameters, inc...
By PharmaVoice Team • April 1, 2021 -
PharmaVoice Team/PharmaVoice
Artificial Intelligence
Iktos Partners with Pfizer for AI-based Drug Design Project Trend Watch: COVID-19, Parkinson’s, Alzheimer’s All Benefiting from AI Platforms Iktos, an AI-based chemical research solution provider, and Pfizer are creating a design model for the pharma company’s selective small molecule discovery p...
By PharmaVoice Team • April 1, 2021 -
PharmaVoice Team/PharmaVoice
Virtual Launches
Industry thought leaders discuss what they learned during their recent pivot to virtual launches. Launching a product in the past year, during a global pandemic, required a nimbleness that often belies a pharma product launch, but several companies accepted the challenge and created new strategie...
By Robin Robinson • April 1, 2021 -
PharmaVoice Team/PharmaVoice
Six Cell and Gene Therapy Commercialization Trends
What to Watch in the Next 12 Months and Beyond 2020 was a noteworthy year for cell and gene therapies (CGT), which conservatively account for 12% of the pharma industry’s clinical pipeline and 16% of its preclinical pipeline. Despite unprecedented global challenges caused by COVID-19, the CGT mar...
By Amy DuRoss • April 1, 2021 -
PharmaVoice Team/PharmaVoice
Precision Medicine and Predictive Action Drive Measurable Impact for Patients
The Institute for Precision Medicine defines “Precision Medicine" as the “medical approach that proposes to prevent and treat disease based upon a person’s unique genetic makeup and their lifestyle habits. Precision medicine, the ability to accurately measure specific predictors of patient outcom...
By Maria Kirsch • April 1, 2021 -
PharmaVoice Team/PharmaVoice
Commanders & Chiefs: Chief Digital Officers
Some say the chief digital officer (CDO) is a “futurist" who predicts trends based on current market conditions and then works to ensure that the business moves to react to those conditions. Others consider the CDO to be that executive who brings together various disciplines within an enterprise ...
By PharmaVoice Team • April 1, 2021 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Thank you… Our special Patient Voice issue is one of my favorite issues of the year. Now in its fourth year, this is our opportunity to shine a light on the people who are truly making a difference to the healthcare system. It’s their unwavering pursuit to change the status quo and improve the de...
By Taren Grom • March 1, 2021 -
PharmaVoice Team/PharmaVoice
Upfront
Lilly and Life for a Child Expand Partnership Lilly, Life for a Child, and Beyond Type 1 advance access to diabetes care in resource-limited countries. More than 1.8 million children and young adults under 25 years old have Type 1 diabetes, yet many don’t have access to the life-saving treatments...
By PharmaVoice Team • March 1, 2021
Previous
